These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21775208)

  • 1. Tackling transcription factors: challenges in antitumor therapy.
    Grivas PD; Kiaris H; Papavassiliou AG
    Trends Mol Med; 2011 Oct; 17(10):537-8. PubMed ID: 21775208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of molecular genetic analysis in selecting antitumor therapy].
    Imianitov EN; Moiseenko VM
    Vopr Onkol; 2008; 54(2):121-32. PubMed ID: 18522159
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
    Marum L
    Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
    [No Abstract]   [Full Text] [Related]  

  • 4. Curing "incurable" cancer.
    Watson JD
    Cancer Discov; 2011 Nov; 1(6):477-80. PubMed ID: 22586652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early evidence for the role of TRIM29 in multiple cancer models.
    Hatakeyama S
    Expert Opin Ther Targets; 2016 Jul; 20(7):767-70. PubMed ID: 26838517
    [No Abstract]   [Full Text] [Related]  

  • 6. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. As we bring demethylating drugs to the clinic, we better know the DICE being cast.
    Lizardi PM
    Oncogene; 2010 Oct; 29(43):5772-4. PubMed ID: 20729909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of transcription factors as agents and targets for drug development.
    Smith LM; Birrer MJ
    Oncology (Williston Park); 1996 Oct; 10(10):1532-8; discussion 1541-2. PubMed ID: 8905845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking cancer with RNA interference moves toward the clinic.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
    [No Abstract]   [Full Text] [Related]  

  • 10. Environmental protection: studies highlight importance of tumor microenvironment.
    Hede K
    J Natl Cancer Inst; 2004 Aug; 96(15):1120-1. PubMed ID: 15292379
    [No Abstract]   [Full Text] [Related]  

  • 11. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From correlation to causality: microarrays, cancer, and cancer treatment.
    O'Neill GM; Catchpoole DR; Golemis EA
    Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
    Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression.
    Ferrari N; Paleari L; Palmisano GL; Tammaro P; Levi G; Albini A; Brigati C
    Oncol Rep; 2003; 10(4):973-7. PubMed ID: 12792755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versipelostatin: unfolding an unsweetened death.
    Sausville EA
    J Natl Cancer Inst; 2004 Sep; 96(17):1266-7. PubMed ID: 15339959
    [No Abstract]   [Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
    Theocharis S; Margeli A; Vielh P; Kouraklis G
    Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction pathways in cancer development and as targets for cancer prevention.
    Bode AM; Dong Z
    Prog Nucleic Acid Res Mol Biol; 2005; 79():237-97. PubMed ID: 16096030
    [No Abstract]   [Full Text] [Related]  

  • 18. Using "rationally designed drugs" rationally.
    Brugarolas J; Clark JW; Chabner B
    Lancet; 2003 May; 361(9371):1758-9. PubMed ID: 12781531
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.
    Strissel PL; Strick R
    Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of eIF4E expression by L-Asparaginase.
    Suto H; Yasuda H; Isobe Y; Sasaki M; Imai H; Tsutsui M; Oshimi K; Komatsu N; Sugimoto K
    Acta Haematol; 2010; 123(4):215-9. PubMed ID: 20424434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.